As Washington lawmakers struggle to find ways to lower drug costs, a new survey finds that a sizable proportion of employers support proposals to eliminate the rebates paid by drug makers to win favorable insurance coverage.
Specifically, 42% of nearly 600 employers support eliminating rebates for both public and private payers, and another 5% were in favor of eliminating them only for government healthcare plans. Just 17% opposed any change to the current rebating system, but 36% have no opinion or want more information, according to the survey conducted last month by the Mercer benefits consulting firm.
About the Author Reprints
